Christine Meyer, Ph.D.
`Senior Vice President
`
`
`NERA Economic Consulting
`360 Hamilton Avenue, 10th Floor
`White Plains, New York 10601
`Tel: 914-448-4119 Fax: 1 (914) 448-4040
`christine.meyer@nera.com
`www.nera.com
`
`
`
`
`
`CHRISTINE MEYER, Ph.D.
`Senior Vice President
`
`
`
`Dr. Meyer conducts economic research and analysis in the areas of intellectual property
`economics, antitrust, commercial damages, business valuation, and labor economics. She has
`written expert reports and testified in deposition and at trial about her economic analysis.
`
`In the areas of intellectual property, commercial damages, and business valuation, Dr. Meyer has
`written expert reports and testified on economic damages. She has analyzed damages arising
`from patent and copyright infringement, the misappropriation of trade secrets, and breaches of
`contract. She has worked on analysis of class certification issues and has analyzed commercial
`success and injunction issues in patent cases. She has also analyzed the value of several patents,
`licenses, and potential business acquisitions.
`
`In antitrust, Dr. Meyer has evaluated the competitive effects of mergers and acquisitions and
`analyzed antitrust claims and damages in cases involving alleged resale price maintenance,
`monopolization and price discrimination. Dr. Meyer has analyzed competition in a wide range of
`industries, including agricultural chemicals, athletic apparel, automotive parts, beer, bread,
`chemicals, computer software, hospitals, kitchen appliances, linen rental, mobile computing,
`movie theaters, pharmaceuticals, satellite ground equipment, smokeless tobacco, and yogurt. Dr.
`Meyer has incorporated various econometric techniques in her antitrust work to include analysis
`of bidding data, demand modeling, and the design and analysis of discrete choice consumer
`surveys. Dr. Meyer has written expert reports and testified about her analysis and has presented
`her analysis to the Federal Trade Commission and Department of Justice. In 2009, she was
`featured as one of Global Competition Review's Women in Antitrust.
`
`In labor economics, Dr. Meyer has conducted academic research and published several papers in
`peer-reviewed journals dealing with issues including work/family benefits, women’s work, and
`childbearing decisions. She has testified on damages in an alleged wrongful termination matter.
`She has also worked on behalf of numerous families of victims of the September 11 terrorist
`attacks to analyze and testify about the economic losses incurred by families in connection with
`their claims to the Federal Victim's Compensation Fund.
`
`
`
`
`
`
`
`
`
`
`
`Page 1
`
`

`

`Christine Meyer, Ph.D.
`
`
`Education
`
`Massachusetts Institute of Technology
`Ph.D., Economics, 1995
`
`United States Military Academy, West Point
`B.S., Economics, 1988
`
`Professional Experience
`
`2015-
`
`NERA Economic Consulting
`Senior Vice President
`
`2002-2006
`
`2006-2015 Vice President
`
`Senior Consultant
`
`Consultant
`
`Colgate University
`1999-2000 Visiting Assistant Professor
`Taught courses in Statistics and Introductory Economics.
`
`2000-2002
`
`Bentley College
`1995-1999 Assistant Professor
`Taught courses in Statistics, Macroeconomics, Money and Banking, and the
`Economics of Race and Gender for undergraduate and graduate students.
`
`1995-1999
`
`Data Resources, Inc.
`Consultant
`Wrote several industry studies for the U.S. Industry and Trade Outlook, a
`Department of Commerce publication. Consulted on local macroeconomic
`forecasts.
`
`Massachusetts Institute of Technology
`1993-1995 Head Teaching Assistant
`Taught courses in Macroeconomics.
`
`1992
`
`Research Assistant
`Developed Fortran programs for Professor Jerry Hausman.
`
`1990-1991
`
`United States Army
`First Lieutenant
`Assistant Battalion Operations Officer and Platoon Leader, 101st Military Police
`Company. Fort Campbell, Kentucky and Operation Desert Shield and Desert
`Storm, Saudi Arabia and Iraq.
`
`
`
`2
`
`Page 2
`
`

`

`1988-1990
`
`Second Lieutenant
`Platoon Leader and Executive Officer, Headquarters Company, Law Enforcement
`Command, Fort Campbell, Kentucky.
`
`Christine Meyer, Ph.D.
`
`
`1987
`
`Office of Management and Budget, Personnel Policy Branch
`Summer Intern
`Analyzed military pay and recruiting.
`
`Honors and Professional Activities
`
`Associate Editor of ABA Section of Antitrust Law, Antitrust Magazine, 2013-2014
`
`Global Competition Review's 100 “Women in Antitrust”, 2009
`
`Patricia Roberts Harris Award for Excellence in Pro Bono, Fried Frank, Harris, Shriver &
`Jacobson LLP, 2004
`
`The Legal Aid Society Pro Bono Award for Assistance to Victims of the World Trade Center
`Tragedy, 2002
`
`Rauch Faculty Enrichment Grant, Bentley College, 1997
`
`Summer Research Grant, Bentley College, 1996 and 1997
`
`National Science Foundation Scholarship, 1992-1994
`
`Army Commendation Medal and Army Achievement Medal, 1990-1991
`
`Testimony (2010 - 2014)
`
`Expert report, supplemental report and trial testimony in Vestergaard Frandsen A/S, Vestergaard
`Frandsen SA, Disease Control Textiles SA v. Bestnet Europe Limited, 3T Europe Limited,
`Intection Limited, Intelligent Insect Control Limited, Torben Holm Larsen, In the High Court of
`Justice, Claim No. HC06C04408, Chancery Division Intellectual Property, Royal Courts of
`Justice, Strand, London, May 15, July 1, and July 3, 2014.
`
`Expert report, supplemental and amended report, reply report, deposition testimony and rebuttal
`direct trial testimony and trial testimony in CCP Systems AG v. Samsung Electronics Corp., Ltd.,
`et al., United States District Court for the District of New Jersey, May 8, May 13, May 21, May
`23, and June 11, and July 8, 2014.
`
`Expert report, rebuttal report and testimony in T-Jat Systems 2006 Ltd. v. Amdocs Software
`Systems Limited, Amdocs Limited, and Amdocs, Inc., The American Arbitration Association
`International Centre for Dispute Resolution, January 31, February 13 and February 20, 2014.
`
`Expert report, deposition testimony, supplemental expert report and trial testimony in Viasat, Inc.,
`Viasat Communications, Inc., f/k/a Wildblue Communications, Inc. v. Space Systems/Loral, Inc.,
`
`
`
`3
`
`Page 3
`
`

`

`Christine Meyer, Ph.D.
`
`
`Loral Space Communications, Inc., United States District Court for the Southern District of
`California, November 25, December 3, 2013 and January 20, April 9, 2014.
`
`Expert report and deposition testimony in On Track Innovations Ltd. v. T-Mobile USA, Inc.,
`United States District Court Southern District of New York, November 4, 2013 and January 9,
`2014.
`
`Expert report and deposition testimony in Space Systems/Loral, Inc., Loral Space &
`Communications, Inc. v. Viasat, Inc., Viasat Communications, Inc., f/k/a Wildblue
`Communications, Inc., United States District Court for the Southern District of California,
`October 25 and December 4, 2013.
`
`Expert report and deposition testimony in Denimafia, Inc. v. New Balance Athletic Shoe, Inc.,
`Foot Locker, Inc., The Sports Authority, Inc., and Famous Horse, Inc. d/b/a V.I.M., United States
`District Court Southern District of New York, September 30 and October 23, 2013.
`
`Expert report and deposition testimony in IP Venture, Inc. v. International Business Machines
`Corporation, United States District Court Southern District of New York, July 2 and September
`11, 2013.
`
`Expert report and deposition testimony in Astrazeneca AB, et al. v. Andrx Corp., et al. In re
`Omeprazole Patent Litigation, United States District Court Southern District of New York, July
`1, and July 30, 2013.
`
`Expert report, deposition testimony, direct testimony declaration, trial testimony and declaration
`in Astrazeneca AB, et al. v. Apotex Corp., et al. In re Omeprazole Patent Litigation, United
`States District Court Southern District of New York, June 5, August 15, September 13,
`November 7, November 12, and, December 6, 2013.
`
`Expert report, reply expert report, and deposition testimony in Volterra Semiconductor
`Corporation v. Primarion, Inc., Infineon Technologies AG, and Infineon Technologies North
`America Corporation, United States District Court for the Northern District of California, May 3,
`July 3, and July 10, 2013.
`
`Expert report and trial testimony in Merck & Co., Inc. and Merck Frosst Canada Ltd. v. Apotex
`Inc. and Apotex Fermentation Inc., Federal Court of Canada, January 25 and April 10, 2013.
`
`Expert report and deposition testimony in Senior Housing Capital, LLC, et al. v. SHP Senior
`Housing Fund, LLC, et al., Court of Chancery of the State of Delaware, September 14, and
`October 18, 2012.
`
`Trial testimony in Luis X. Rojas and Maria Rojas v. Andrew Paine, et al, Supreme Court of the
`State of New York, County of Westchester, June 18, 2012.
`
`Expert report and trial testimony in Briese Lichttechnik Vertriebs GmbH and Hans-Werner
`Briese v. Brent Langton, B2Pro, Key Lighting, Inc. and Sergio Ortiz, United States District Court
`for the Southern District of New York, November 28, 2011 and October 4 and 7, 2013.
`
`
`
`4
`
`Page 4
`
`

`

`Christine Meyer, Ph.D.
`
`
`Expert report, deposition testimony and trial testimony in United States of America, U.S.
`Department of Justice v. H&R Block, Inc., 2SS Holdings, Inc., TA IX L.P., United States District
`Court for the District of Columbia, August 12 and 22, September 12, 13 and 15, 2011.
`
`Expert report and trial testimony in Waddington North America, Inc. v. Sabert Corporation,
`United States District Court, District of New Jersey, January 13, 2011, and March 30, April 1,
`and April 4, 2011.
`
`Expert report and deposition testimony in MacroMavens, LLC v. Deutsche Bank Securities, Inc.,
`United States District Court, Southern District of New York, October 15, and November 10,
`2010.
`
`Publications (2004 – 2014)
`
`“High Court Brings Economics Back to Pay-For-Delay Analysis” June 17, 2013, Law360, (with
`Sumanth Addanki and Alan Daskin).
`
`“A Comprehensive Look at the Critical Loss Analysis in a Differentiated Products Merger”,
`2012, Journal of Competition Law & Economics, 8(4):863-879 (with Yijia Wang).
`
`“25 Percent, 50 Percent … What’s in a Number?” June 21, 2011, IP Law 360, (with David
`Blackburn).
`
`"Determining the Competitive Effects of Vertical Integration in Mergers", Summer 2011,
`ABA Section of Antitrust Law Economics Committee Newsletter, 11(1) (with Isabelle Wang).
`
`“Merger Guidelines Revisited?” Fall 2009, Antitrust, 24(1):8-21 (with Deborah Feinstein, Mark
`D. Whitener, Paul T. Denis, and Dennis W. Carlton).
`
`“Investigating Dual Labor Market Theory For Women,” 2007, Eastern Economic Journal, 33(3)
`(with Swati Mukerjee).
`
`“Don’t Feed the Trolls?” 2007, les Nouvelles. Sept 2007: 487-495 (with John Johnson, Gregory
`Leonard and Ken Serwin). Also reprinted in Patent Trolls: Legal Implications. Hyderabad,
`India, Icfai University Press.
`
`“Reasonable Royalties after eBay.” 2007, IP Law 360. (with David Blackburn).
`
`“Designing and Using Surveys to Define Relevant Markets.” 2007, in Economics of Antitrust:
`Complex Issues in a Dynamic Economy. White Plains, NY, NERA Economic Consulting.
`
`“A Critique of Noneconomic Methods of Reasonable Royalty Calculation.” 2005, in Economic
`Approaches to Intellectual Property. White Plains, NY, NERA Economic Consulting (with
`Bryan Ray).
`
`“Interest and Discount Rates in Intellectual Property Damages.” 2005, in Economic Approaches
`to Intellectual Property. White Plains, NY, NERA Economic Consulting (with Jesse David).
`
`
`
`5
`
`Page 5
`
`

`

`Exhibit 2
`
`Materials Relied Upon for the
`Declaration of Christine Siegwarth Meyer, Ph.D. in Support of Petitioner’s
`Reply
`
`
`
`Board Papers
`
`Paper 25
`
`
`
`Exhibits
`
`Exhibit 1001
`
`Exhibit 1003
`
`Exhibit 1011
`
`Exhibit 2007
`
`Exhibit 2038
`
`Exhibit 2048
`
`Exhibit 2050
`
`
`
`Other
`
`2010 Reckitt Benckiser Group Annual Report.
`
`2011 Reckitt Benckiser Group Annual Report.
`
`2013 Reckitt Benckiser Group Annual Report .
`
`“Developing Products for Rare Diseases & Conditions,” available at
`
`http://www.fda.gov/forindustry/DevelopingProduCTsforrareDiseasesCondition
`
`s/default.htm.
`
`Fed. Reg. 2013-13446, Jun. 6, 2013.
`
`“Frequently Asked Questions on Patents and Exclusivity,” available at
`
`http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ucm079031.htm.
`
`
`
`
`
`
`
`
`
`
`
`
`1
`
`Page 6
`
`

`

`Exhibit 2
`
`“Further US RB Pharmaceuticals Announcement,” September 25, 2012, available
`
`at
`
`http://www.rb.com/site/rkbr/templates/mediainvestorsgeneral2.aspx?pageid=13
`
`32&cc=GB.
`
`Jessie Cheng, An Antitrust Analysis of Product Hopping in the Pharmaceutical
`
`Industry, Columbia Law Review, Issue 6, October 2008.
`
`Lachman Consultant Services, Inc. Citizen Petition, September 27, 2012 (Docket
`
`No. FDA–2012–P–1034).
`
`M. Sean Royall, Ashely E. Johnson, and Jason C. McKenney, “Antitrust Scrutiny
`
`of Pharmaceutical ‘Product Hopping,’” Antitrust, Vol. 28, No. 1, Fall 2013.
`
`“National Drug Code Directory,” available at
`
`http://www.accessdata.fda.gov/scripts/cder/ndc/default.cfm (Type: Active
`
`Ingredient; Name: buprenorphine).
`
`Product Improvements and Life Cycle Management – Antitrust Pitfalls,
`
`Presentation by the New Jersey Intellectual Property Law Association,
`
`available at
`
`http://www.njipla.org/Resources/Documents/event_proceedings/2012-12-05-
`
`26th-Annual-Pharmaceutical-
`
`Chemical/NJIPLA%20Presentation%20on%20Product%20Switching---
`
`Final%20Paper%20NY02%20760911%201-2.pdf.
`
`“Proposed Demerger of the RB Pharmaceuticals business,” Reckitt Benckiser
`
`Group Press Release, November 17, 2014, available at
`
`https://www.rb.com/proposed-demerger-of-the-rb-pharmaceuticals-business.
`
`“US FDA Marketing Approval For Reckitt Benckiser’s Subutex® & Suboxone®,”
`
`Reckitt Benckiser Press Release, October 9, 2002, available at
`
`https://www.rb.com/documentdownload.axd?documentresourceid=8.
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`Page 7
`
`